通过SynNotch受体工程提高自然杀手细胞的抗瘤效率,以准IL-12分泌
Ali Ahmadnia1, Saeed Mohammadi2, Ahad Yamchi3
1Department of Molecular Medicine, Faculty of Advanced Medical Technologies, Golestan University of Medical Sciences, Gorgan P.O. Box 665, Iran.
Current issues in molecular biology
|April 26, 2024
概括
带有PD1合成Notch (synNotch) 受体的工程自然杀手 (NK) 细胞显示出增强的抗瘤活性. 这种方法可以提高NK细胞的细胞毒性和细胞因子的产生,对抗PD-L1阳性乳腺癌细胞.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 生物技术是生物技术.
背景情况:
- 自然杀手 (NK) 细胞对于先天免疫和瘤监测至关重要.
- 优化NK细胞的仿制抗原受体 (CAR) 对于有效的癌症免疫疗法至关重要.
- 卡尔-NK细胞提供了减少副作用和可扩展生产的潜力.
研究的目的:
- 通过对NK细胞进行 PD1 合成的 Notch (synNotch) 受体的工程来增强NK细胞的抗瘤活性.
- 评估synNotch受体工程NK细胞对PD-L1阳性乳腺癌细胞的疗效.
主要方法:
- 使用UniProt序列和3D建模设计的嵌合体受体.
- 通过lentiviral转导引入PD1-Syn受体进入NK细胞.
- 评估了与乳腺癌细胞共培养的受体表达,细胞毒性活性和细胞因子 (IL-12,IFNγ) 生产.
主要成果:
- 在工程NK细胞上成功表达PD1-Syn受体.
- 卡尔-NK细胞以依赖于标的方式分泌IL-12并产生IFNγ.
- 对PD-L1+乳腺癌细胞显著增强,依赖于标的细胞毒性活性.
结论:
- PD1-synNotch受体工程增强NK细胞的抗瘤功能.
- 这一策略显示出改善免疫疗法的前景,特别是在高PD-L1表达的乳腺癌中.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
903
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
903
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520


